bioMérieux UK v Labrador Diagnostics (CoA, 17 February 2026)
| Date | 17 February 2026 |
|---|---|
| Court | CoA |
| Division | Luxembourg (LU) |
| Type of action | Appeal RoP220.1 |
| Case number(s) | UPC_CoA_937/2025;UPC_CoA_938/2025 |
| Registry reference | UPC-COA-0000937/2025 · UPC-COA-0000938/2025 |
| Parties | bioMérieux UK Limited, bioMérieux Benelux BV, bioMérieux SA, bioMérieux Deutschland GmbH, bioMérieux Portugal, Lda., bioMérieux Italia S.p.… |
Official decision (PDF) · UPC registry entry
Dhenne Avocats represents claimants and defendants in European patent disputes before the Unified Patent Court, including the Paris divisions.
Dhenne Avocats · 10 October 2026
Our analysis
Summary
In an order of 17 February 2026 (UPC_CoA_937/2025 and UPC_CoA_938/2025), the judge-rapporteur of the Court of Appeal refused the bioMérieux companies, appealing the Milan Central Division decision of 23 October 2025 maintaining Labrador Diagnostics’ EP 3 756 767 in amended form, both a stay pending EPO opposition proceedings and an extension of the deadline for the statement of grounds of appeal.
Question
Should appeal proceedings be stayed where the EPO Opposition Division is due to decide shortly and has issued a preliminary opinion favouring revocation, and should the deadline for the grounds of appeal be extended to align with a possible infringement appeal?
Decision
As a rule the court does not stay proceedings, and parallel opposition does not in itself justify an exception (paragraphs 13 and 14). Even where an EPO decision is expected rapidly, a stay remains discretionary (paragraphs 16 to 19): the Opposition Division decision will arrive during the appeal and can be relied on then, so a stay would serve no purpose and cause unjustified delay (paragraphs 20 to 23). An extension under Rule 9.3(a) requires exceptional circumstances, absent here: the appellants do not need the opposition outcome to state their grounds, the infringement appeal is merely possible, and hearing the appeals together under Rule 220.5 would achieve alignment (paragraphs 24 to 29).
Key points for practice
- A preliminary Opposition Division opinion favouring revocation is not enough to stay a UPC revocation appeal (paragraphs 14 to 23).
- Practical point: to coordinate revocation and infringement appeals, ask for a joint hearing under Rule 220.5 rather than a time extension (paragraph 28).
Provisions applied
- Agreement on a Unified Patent Court
- Art. 33(10)
- Rules of Procedure
- Rules 9.3(a), 220.5 and 295(a)
- Case law cited
- Carrier v Bitzer, Court of Appeal, 28 May 2024, Juul v NJOY, Court of Appeal, 30 April 2025 (UPC_CoA_5/2025), Meril v Edwards, Court of Appeal, 21 November 2024, Bega v Washtower, Court of Appeal, 24 September 2025
Prepared by Dhenne Avocats from the official decision, consulted on 10 October 2026. The database is updated every week, on Friday. Only the official text is authoritative.
Going further
Lexicon: UPC Court of Appeal.
Dhenne Avocats blog: UPC Appeals: What the Numbers Show.
Source and translations
- Official source
- Unified Patent Court registry link recorded in the record
- Original language
- not recorded
- Translation available
- no translation recorded the firm’s French record is a summary, not a translation
- Date checked
- not recorded
Follow this case
Proceedings, related decisions, appeals, parties and patents as recorded in the registry and in the Dhenne Avocats corpus. Each link states its source.
Parties
- claimantbioMérieux UK Limited, bioMérieux Benelux BV, bioMérieux SA, bioMérieux Deutschland GmbH, bioMérieux Portugal, Lda., bioMérieux Italia S.pFollow this party
Decisions in the same proceedings and documented appeals
What the record states
- Nature of the act
- Appeal RoP220.1
- Outcome (Dhenne Avocats summary)
- Le juge rapporteur refuse le sursis à statuer dans l'attente de l'opposition devant l'OEB et la prorogation du délai du mémoire d'appel, faute d'utilité et de circonstances exceptionnelles.
- Appeal
- Decision of the Court of Appeal.
- Instance
- Court of Appeal decision.
Patents mentioned
EP 3 756 767mentioned in: Dhenne Avocats analysis Follow this patent
Related decisions cited in the analyses
- Industriebeteiligungs- und Beratungs v Washtower IP (CoA, 24 September 2025) cited in this record
- Meril Life Sciences v Edwards Lifesciences (CoA, 21 November 2024) cited in this record
- Carrier v BITZER Electronics (CoA, 28 May 2024) cited in this record
- Canfield Scientific v QUANTIFICARE (CoA, 2 October 2026) cites this decision
Patents and standards
| Publication | Role in the dispute | Family | Standard and declaration | Pool | Sources |
|---|---|---|---|---|---|
EP 3 756 767 | Mentioned in the analysis (role not qualified) Also mentioned in 5 other decision(s): Labrador Diagnostics v bioMérieux (CFI, 28 January 2026) · bioMérieux UK v Labrador Diagnostics (CFI, 23 October 2025) · Labrador Diagnostics v bioMérieux (CFI, 26 September 2025) · bioMérieux v Labrador Diagnostics (CFI, 18 July 2025) · Labrador Diagnostics v bioMérieux (CFI, 23 April 2025) | not recorded | not recorded | not recorded | Espacenet links not checked mentioned in: Dhenne Avocats analysis |
Receive an alert
Weekly summary of new records and substantive updates matching what you follow. Address confirmed by email, unsubscribe at any time, one email per week even where several of your follows match.